Related Party Transactions |
3 Months Ended |
|---|---|
Mar. 31, 2020 | |
| Related Party Transaction, Due from (to) Related Party [Abstract] | |
| Related Party Transactions | Related Party Transactions AstraZeneca PLC
Pam P. Cheng, a member of our board of directors, joined AstraZeneca PLC as Executive Vice President, Operations and Information Technology in June 2015. We sell biocatalyst products to AstraZeneca PLC and its controlled purchasing agents and contract manufacturers.
We recognized $0.1 million and nominal revenue in the three months ended March 31, 2020, and 2019, respectively, from transactions with AstraZeneca PLC and its controlled purchasing agents and contract manufacturers. At March 31, 2020 and December 31, 2019, we had $0.1 million and $0.3 million of receivables from AstraZeneca PLC and its controlled purchasing agents and contract manufacturers, respectively.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|